Biomarker for Rapid Diagnosis of Hemispheric Stroke

Johann Wolfgang Goethe University Hospital1 site in 1 country250 target enrollmentJune 2009

ConditionsAcute Stroke

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Acute Stroke
Sponsor: Johann Wolfgang Goethe University Hospital
Enrollment: 250
Locations: 1
Primary Endpoint: Diagnostic accuracy (sensitivity and specificity for diagnosing cerebral ischemia and intracerebral hemorrhage)
Status: Completed
Last Updated: 14 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.

Registry

clinicaltrials.gov

Start Date

June 2009

End Date

June 2011

Last Updated

14 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Johann Wolfgang Goethe University Hospital

Eligibility Criteria

Inclusion Criteria

•hemiparesis
•at least one sign of cortical involvement (e.g., aphasia, neglect, gaze deviation, reduced level of consciousness)
•hospital admission within 4.5 hours after symptom onset